Company / Shareholders' Equity
FILANA THERAPEUTICS, INC. Shareholders' Equity History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$48.3M
FY2015
5-year range
$13.1M / $108.3M
FY2011-FY2015
Trend
+267.7%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +268% YoY in FY2015, a notable deviation from the 4-year average annual change of +41%.
Based on SEC 10-K filings.
$48M in FY2015 with a 3-year CAGR of +13.6%.
Improved from $44M to $48M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +13.6%, indicating consistent growth.
- In FY2015, shareholders' equity increased 267.7% year-over-year.
- Peak shareholders' equity was recorded in FY2011.
- Lowest shareholders' equity in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $48.3M | +267.7% |
| FY2014 | $13.1M | -70.4% |
| FY2013 | $44.4M | +34.8% |
| FY2012 | $32.9M | -69.6% |
| FY2011 | $108.3M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026